Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-25-000160
Filing Date
2025-07-17
Accepted
2025-07-17 16:54:31
Documents
1
Period of Report
2025-07-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5976
  Complete submission text file 0000874015-25-000160.txt   7453
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address
WENDER JOSEPH H (Reporting) CIK: 0001073384 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 251131241